AEZS -a biotech with good potential and a NOV PDUFA along with a very possible ADCOM announcement in advance of that. Recent article place value at roughly 3x current. Last stock offering was @ 1.30 stock currently at $1.40 - watch this one should be interesting before long. Bios are volatile as heck so keep your eye on it for better (a jump day of approval), or in the case of a failed drug worse on the day of failure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.